Contec Medical Systems Co Ltd - Asset Resilience Ratio
Contec Medical Systems Co Ltd (300869) has an Asset Resilience Ratio of 22.69% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Contec Medical Systems Co Ltd's Asset Resilience Ratio has changed over time. Check how strategically is Contec Medical Systems Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Contec Medical Systems Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Contec Medical Systems Co Ltd market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥633.33 Million | 22.69% |
| Total Liquid Assets | CN¥633.33 Million | 22.69% |
Asset Resilience Insights
- Good Liquidity Position: Contec Medical Systems Co Ltd maintains a healthy 22.69% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Contec Medical Systems Co Ltd Industry Peers by Asset Resilience Ratio
Compare Contec Medical Systems Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for Contec Medical Systems Co Ltd (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Contec Medical Systems Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 6.30% | CN¥171.59 Million ≈ $25.11 Million |
CN¥2.73 Billion ≈ $398.83 Million |
-14.00pp |
| 2023-12-31 | 20.30% | CN¥652.02 Million ≈ $95.41 Million |
CN¥3.21 Billion ≈ $470.01 Million |
+19.05pp |
| 2022-12-31 | 1.25% | CN¥46.64 Million ≈ $6.82 Million |
CN¥3.73 Billion ≈ $546.23 Million |
-5.56pp |
| 2021-12-31 | 6.81% | CN¥189.98 Million ≈ $27.80 Million |
CN¥2.79 Billion ≈ $408.12 Million |
-- |
About Contec Medical Systems Co Ltd
Contec Medical Systems Co.,Ltd engages in the research and development, production, and sale of medical diagnosis and monitoring equipment in China and internationally. The company offers electronic sphygmomanometers, ambulatory blood pressure monitors, pulse oximeters, patient monitors, stethoscopes, simulators, multi-parameter vital signs monitors, central monitoring systems, electrocardiograph… Read more